UniProtKB/Swiss-Prot Q13114: Variant p.Met129Thr

TNF receptor-associated factor 3
Gene: TRAF3
Feedback?

Variant information Variant position:

129 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Methionine (M) to Threonine (T) at position 129 (M129T, p.Met129Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (M) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1131877 [ dbSNP | Ensembl ]

Sequence information Variant position:

129 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

568 The length of the canonical sequence.
Location on the sequence:

EILALQIYCRNESRGCAEQL M LGHLLVHLKNDCHFEELPCV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EILALQIYCRNESRGCAEQLMLGHLLVHLKNDCHFEELPCV

Mouse                         EILALQVYCRNEGRGCAEQLTLGHLLVHLKNECQFEELPCL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 568	TNF receptor-associated factor 3
Cross	124 – 124	Glycyl cysteine thioester (Cys-Gly) (interchain with G-Cter in ubiquitin)
Mutagenesis	124 – 124	C -> A. Strong increase in both 'Lys-48' and 'Lys-63'-linked ubiquitination.

Literature citations
A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40.
Sato T.; Irie S.; Reed J.C.;
FEBS Lett. 358:113-118(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); INTERACTION WITH TNFRSF5; VARIANT THR-129; Involvement of CRAF1, a relative of TRAF, in CD40 signaling.
Cheng G.; Cleary A.M.; Ye Z.S.; Hong D.I.; Lederman S.; Baltimore D.;
Science 267:1494-1498(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); INTERACTION WITH TNFRSF5; VARIANT THR-129;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.